{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,18]],"date-time":"2026-08-18T16:11:18Z","timestamp":1787069478681,"version":"build-2736575974"},"reference-count":43,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2023,11,4]],"date-time":"2023-11-04T00:00:00Z","timestamp":1699056000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2023,11,4]],"date-time":"2023-11-04T00:00:00Z","timestamp":1699056000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/100000062","name":"National Institute of Diabetes and Digestive and Kidney Diseases","doi-asserted-by":"publisher","award":["R01DK098410"],"award-info":[{"award-number":["R01DK098410"]}],"id":[{"id":"10.13039\/100000062","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000062","name":"National Institute of Diabetes and Digestive and Kidney Diseases","doi-asserted-by":"publisher","award":["R01DK120908"],"award-info":[{"award-number":["R01DK120908"]}],"id":[{"id":"10.13039\/100000062","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000062","name":"National Institute of Diabetes and Digestive and Kidney Diseases","doi-asserted-by":"publisher","award":["R01DK115968"],"award-info":[{"award-number":["R01DK115968"]}],"id":[{"id":"10.13039\/100000062","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000062","name":"National Institute of Diabetes and Digestive and Kidney Diseases","doi-asserted-by":"publisher","award":["R01DK103564"],"award-info":[{"award-number":["R01DK103564"]}],"id":[{"id":"10.13039\/100000062","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Cell Biosci"],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>\n                      People of Sub-Saharan African ancestry are at higher risk of developing chronic kidney disease (CKD), attributed to the\n                      <jats:italic>Apolipoprotein L1<\/jats:italic>\n                      (\n                      <jats:italic>APOL1<\/jats:italic>\n                      ) gene risk alleles (RA) G1 and G2. The underlying mechanisms by which the APOL1-RA precipitate CKD remain elusive, hindering the development of potential treatments.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>\n                      Using a\n                      <jats:italic>Drosophila<\/jats:italic>\n                      genetic modifier screen, we found that SNARE proteins (Syx7, Ykt6, and Syb) play an important role in preventing APOL1 cytotoxicity. Reducing the expression of these SNARE proteins significantly increased APOL1 cytotoxicity in fly nephrocytes, the equivalent of mammalian podocytes, whereas overexpression of\n                      <jats:italic>Syx7<\/jats:italic>\n                      ,\n                      <jats:italic>Ykt6<\/jats:italic>\n                      , or\n                      <jats:italic>Syb<\/jats:italic>\n                      attenuated their toxicity in nephrocytes. These SNARE proteins bound to APOL1-G0 with higher affinity than APOL1-G1\/G2, and attenuated APOL1-G0 cytotoxicity to a greater extent than either APOL1-RA.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusions<\/jats:title>\n                    <jats:p>\n                      Using a\n                      <jats:italic>Drosophila<\/jats:italic>\n                      screen, we identified SNARE proteins (Syx7, Ykt6, and Syb) as antagonists of APOL1-induced cytotoxicity by directly binding APOL1. These data uncovered a new potential protective role for certain SNARE proteins in the pathogenesis of APOL1-CKD and provide novel therapeutic targets for\n                      <jats:italic>APOL1<\/jats:italic>\n                      -associated nephropathies.\n                    <\/jats:p>\n                  <\/jats:sec>","DOI":"10.1186\/s13578-023-01147-8","type":"journal-article","created":{"date-parts":[[2023,11,4]],"date-time":"2023-11-04T03:01:58Z","timestamp":1699066918000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":8,"title":["A SNARE protective pool antagonizes APOL1 renal toxicity in Drosophila nephrocytes"],"prefix":"10.1186","volume":"13","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-9477-6990","authenticated-orcid":false,"given":"Jin-Gu","family":"Lee","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7991-9965","authenticated-orcid":false,"given":"Yulong","family":"Fu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4517-101X","authenticated-orcid":false,"given":"Jun-yi","family":"Zhu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7065-6396","authenticated-orcid":false,"given":"Pei","family":"Wen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1903-7295","authenticated-orcid":false,"given":"Joyce","family":"van de Leemput","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2223-9584","authenticated-orcid":false,"given":"Patricio E.","family":"Ray","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5177-7798","authenticated-orcid":false,"given":"Zhe","family":"Han","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2023,11,4]]},"reference":[{"issue":"5993","key":"1147_CR1","doi-asserted-by":"publisher","first-page":"841","DOI":"10.1126\/science.1193032","volume":"329","author":"G Genovese","year":"2010","unstructured":"Genovese G, Friedman DJ, Ross MD, Lecordier L, Uzureau P, Freedman BI, et al. Association of trypanolytic ApoL1 variants with kidney disease in African Americans. Science. 2010;329(5993):841\u20135.","journal-title":"Science"},{"issue":"7","key":"1147_CR2","doi-asserted-by":"publisher","first-page":"698","DOI":"10.1038\/ki.2010.251","volume":"78","author":"G Genovese","year":"2010","unstructured":"Genovese G, Tonna SJ, Knob AU, Appel GB, Katz A, Bernhardy AJ, et al. A risk allele for focal segmental glomerulosclerosis in African Americans is located within a region containing APOL1 and MYH9. Kidney Int. 2010;78(7):698\u2013704.","journal-title":"Kidney Int"},{"issue":"3","key":"1147_CR3","doi-asserted-by":"publisher","first-page":"345","DOI":"10.1007\/s00439-010-0861-0","volume":"128","author":"S Tzur","year":"2010","unstructured":"Tzur S, Rosset S, Shemer R, Yudkovsky G, Selig S, Tarekegn A, et al. Missense mutations in the APOL1 gene are highly associated with end stage kidney disease risk previously attributed to the MYH9 gene. Hum Genet. 2010;128(3):345\u201350.","journal-title":"Hum Genet"},{"issue":"6927","key":"1147_CR4","doi-asserted-by":"publisher","first-page":"83","DOI":"10.1038\/nature01461","volume":"422","author":"L Vanhamme","year":"2003","unstructured":"Vanhamme L, Paturiaux-Hanocq F, Poelvoorde P, Nolan DP, Lins L, Van Den Abbeele J, et al. Apolipoprotein L-I is the trypanosome lytic factor of human serum. Nature. 2003;422(6927):83\u20137.","journal-title":"Nature"},{"issue":"9","key":"1147_CR5","doi-asserted-by":"publisher","first-page":"1422","DOI":"10.1681\/ASN.2010070730","volume":"21","author":"BI Freedman","year":"2010","unstructured":"Freedman BI, Kopp JB, Langefeld CD, Genovese G, Friedman DJ, Nelson GW, et al. The apolipoprotein L1 (APOL1) gene and nondiabetic nephropathy in African Americans. J Am Soc Nephrol. 2010;21(9):1422\u20136.","journal-title":"J Am Soc Nephrol"},{"issue":"3","key":"1147_CR6","doi-asserted-by":"publisher","first-page":"386","DOI":"10.1111\/j.1365-2141.2011.08832.x","volume":"155","author":"AE Ashley-Koch","year":"2011","unstructured":"Ashley-Koch AE, Okocha EC, Garrett ME, Soldano K, De Castro LM, Jonassaint JC, et al. MYH9 and APOL1 are both associated with sickle cell disease nephropathy. Br J Haematol. 2011;155(3):386\u201394.","journal-title":"Br J Haematol"},{"issue":"5","key":"1147_CR7","doi-asserted-by":"publisher","first-page":"722","DOI":"10.1681\/ASN.2012121180","volume":"24","author":"CP Larsen","year":"2013","unstructured":"Larsen CP, Beggs ML, Saeed M, Walker PD. Apolipoprotein L1 risk variants associate with systemic lupus erythematosus-associated collapsing glomerulopathy. J Am Soc Nephrol. 2013;24(5):722\u20135.","journal-title":"J Am Soc Nephrol"},{"issue":"2","key":"1147_CR8","doi-asserted-by":"publisher","first-page":"390","DOI":"10.1002\/art.38220","volume":"66","author":"BI Freedman","year":"2014","unstructured":"Freedman BI, Langefeld CD, Andringa KK, Croker JA, Williams AH, Garner NE, et al. End-stage renal disease in African Americans with lupus nephritis is associated with APOL1. Arthritis Rheumatol. 2014;66(2):390\u20136.","journal-title":"Arthritis Rheumatol"},{"issue":"11","key":"1147_CR9","doi-asserted-by":"publisher","first-page":"969","DOI":"10.1056\/NEJMoa2202396","volume":"388","author":"O Egbuna","year":"2023","unstructured":"Egbuna O, Zimmerman B, Manos G, Fortier A, Chirieac MC, Dakin LA, et al. Inaxaplin for proteinuric kidney disease in persons with two APOL1 variants. N Engl J Med. 2023;388(11):969\u201379.","journal-title":"N Engl J Med"},{"issue":"5","key":"1147_CR10","doi-asserted-by":"publisher","first-page":"1025","DOI":"10.1111\/j.1600-6143.2011.03513.x","volume":"11","author":"AM Reeves-Daniel","year":"2011","unstructured":"Reeves-Daniel AM, DePalma JA, Bleyer AJ, Rocco MV, Murea M, Adams PL, et al. The APOL1 gene and allograft survival after kidney transplantation. Am J Transplant. 2011;11(5):1025\u201330.","journal-title":"Am J Transplant"},{"issue":"6","key":"1147_CR11","doi-asserted-by":"publisher","first-page":"530","DOI":"10.1016\/j.semnephrol.2017.07.006","volume":"37","author":"BI Freedman","year":"2017","unstructured":"Freedman BI, Locke JE, Reeves-Daniel AM, Julian BA. Apolipoprotein L1 gene effects on kidney transplantation. Semin Nephrol. 2017;37(6):530\u20137.","journal-title":"Semin Nephrol"},{"issue":"4","key":"1147_CR12","doi-asserted-by":"publisher","first-page":"1309","DOI":"10.1681\/ASN.2017060658","volume":"29","author":"MD Doshi","year":"2018","unstructured":"Doshi MD, Ortigosa-Goggins M, Garg AX, Li L, Poggio ED, Winkler CA, et al. APOL1 genotype and renal function of black living donors. J Am Soc Nephrol. 2018;29(4):1309\u201316.","journal-title":"J Am Soc Nephrol"},{"issue":"3","key":"1147_CR13","doi-asserted-by":"publisher","first-page":"F326","DOI":"10.1152\/ajprenal.00647.2013","volume":"307","author":"X Lan","year":"2014","unstructured":"Lan X, Jhaveri A, Cheng K, Wen H, Saleem MA, Mathieson PW, et al. APOL1 risk variants enhance podocyte necrosis through compromising lysosomal membrane permeability. Am J Physiol Renal Physiol. 2014;307(3):F326\u201336.","journal-title":"Am J Physiol Renal Physiol"},{"issue":"8","key":"1147_CR14","doi-asserted-by":"publisher","first-page":"1583","DOI":"10.1194\/jlr.M059733","volume":"56","author":"D Cheng","year":"2015","unstructured":"Cheng D, Weckerle A, Yu Y, Ma L, Zhu X, Murea M, et al. Biogenesis and cytotoxicity of APOL1 renal risk variant proteins in hepatocytes and hepatoma cells. J Lipid Res. 2015;56(8):1583\u201393.","journal-title":"J Lipid Res"},{"issue":"1","key":"1147_CR15","doi-asserted-by":"publisher","first-page":"139","DOI":"10.1016\/j.yexmp.2015.06.003","volume":"99","author":"X Lan","year":"2015","unstructured":"Lan X, Wen H, Lederman R, Malhotra A, Mikulak J, Popik W, et al. Protein domains of APOL1 and its risk variants. Exp Mol Pathol. 2015;99(1):139\u201344.","journal-title":"Exp Mol Pathol"},{"issue":"3","key":"1147_CR16","doi-asserted-by":"publisher","first-page":"491","DOI":"10.1016\/j.yexmp.2015.03.020","volume":"98","author":"X Lan","year":"2015","unstructured":"Lan X, Wen H, Saleem MA, Mikulak J, Malhotra A, Skorecki K, et al. Vascular smooth muscle cells contribute to APOL1-induced podocyte injury in HIV milieu. Exp Mol Pathol. 2015;98(3):491\u2013501.","journal-title":"Exp Mol Pathol"},{"issue":"1","key":"1147_CR17","doi-asserted-by":"publisher","first-page":"C22","DOI":"10.1152\/ajpcell.00384.2014","volume":"309","author":"AK Khatua","year":"2015","unstructured":"Khatua AK, Cheatham AM, Kruzel ED, Singhal PC, Skorecki K, Popik W. Exon 4-encoded sequence is a major determinant of cytotoxicity of apolipoprotein L1. Am J Physiol Cell Physiol. 2015;309(1):C22-37.","journal-title":"Am J Physiol Cell Physiol"},{"issue":"4","key":"1147_CR18","doi-asserted-by":"publisher","first-page":"830","DOI":"10.1073\/pnas.1522913113","volume":"113","author":"OA Olabisi","year":"2016","unstructured":"Olabisi OA, Zhang J-Y, VerPlank L, Zahler N, DiBartolo S 3rd, Heneghan JF, et al. APOL1 kidney disease risk variants cause cytotoxicity by depleting cellular potassium and inducing stress-activated protein kinases. Proc Natl Acad Sci U S A. 2016;113(4):830\u20137.","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"12","key":"1147_CR19","doi-asserted-by":"publisher","first-page":"3600","DOI":"10.1681\/ASN.2015111220","volume":"27","author":"LA Bruggeman","year":"2016","unstructured":"Bruggeman LA, Wu Z, Luo L, Madhavan SM, Konieczkowski M, Drawz PE, et al. APOL1-G0 or APOL1-G2 transgenic models develop preeclampsia but not kidney disease. J Am Soc Nephrol. 2016;27(12):3600\u201310.","journal-title":"J Am Soc Nephrol"},{"issue":"4","key":"1147_CR20","doi-asserted-by":"publisher","first-page":"429","DOI":"10.1038\/nm.4287","volume":"23","author":"P Beckerman","year":"2017","unstructured":"Beckerman P, Bi-Karchin J, Park ASD, Qiu C, Dummer PD, Soomro I, et al. Transgenic expression of human APOL1 risk variants in podocytes induces kidney disease in mice. Nat Med. 2017;23(4):429\u201338.","journal-title":"Nat Med"},{"issue":"11","key":"1147_CR21","doi-asserted-by":"publisher","first-page":"2508","DOI":"10.1016\/j.ajpath.2018.07.025","volume":"188","author":"V Kumar","year":"2018","unstructured":"Kumar V, Vashistha H, Lan X, Chandel N, Ayasolla K, Shoshtari SSM, et al. Role of apolipoprotein L1 in human parietal epithelial cell transition. Am J Pathol. 2018;188(11):2508\u201328.","journal-title":"Am J Pathol"},{"key":"1147_CR22","doi-asserted-by":"publisher","first-page":"188","DOI":"10.1038\/s42003-018-0188-2","volume":"1","author":"K Okamoto","year":"2018","unstructured":"Okamoto K, Rausch JW, Wakashin H, Fu Y, Chung J-Y, Dummer PD, et al. APOL1 risk allele RNA contributes to renal toxicity by activating protein kinase R. Commun Biol. 2018;1:188.","journal-title":"Commun Biol"},{"key":"1147_CR23","doi-asserted-by":"publisher","DOI":"10.1172\/jci.insight.126124","author":"M Aghajan","year":"2019","unstructured":"Aghajan M, Booten SL, Althage M, Hart CE, Ericsson A, Maxvall I, et al. Antisense oligonucleotide treatment ameliorates IFN-\u03b3-induced proteinuria in APOL1-transgenic mice. JCI Insight. 2019. https:\/\/doi.org\/10.1172\/jci.insight.126124.","journal-title":"JCI Insight"},{"issue":"1","key":"1147_CR24","doi-asserted-by":"publisher","first-page":"371","DOI":"10.1186\/s12882-020-01995-3","volume":"21","author":"H Wakashin","year":"2020","unstructured":"Wakashin H, Heymann J, Roshanravan H, Daneshpajouhnejad P, Rosenberg A, Shin MK, et al. APOL1 renal risk variants exacerbate podocyte injury by increasing inflammatory stress. BMC Nephrol. 2020;21(1):371.","journal-title":"BMC Nephrol"},{"key":"1147_CR25","doi-asserted-by":"publisher","DOI":"10.1242\/dmm.048952","author":"GM McCarthy","year":"2021","unstructured":"McCarthy GM, Blasio A, Donovan OG, Schaller LB, Bock-Hughes A, Magraner JM, et al. Recessive, gain-of-function toxicity in an APOL1 BAC transgenic mouse model mirrors human APOL1 kidney disease. Dis Model Mech. 2021. https:\/\/doi.org\/10.1242\/dmm.048952.","journal-title":"Dis Model Mech"},{"key":"1147_CR26","doi-asserted-by":"publisher","DOI":"10.3389\/fmed.2021.762901","volume":"8","author":"T Yoshida","year":"2021","unstructured":"Yoshida T, Latt KZ, Heymann J, Kopp JB. Lessons from APOL1 animal models. Front Med. 2021;8: 762901.","journal-title":"Front Med"},{"issue":"4","key":"1147_CR27","doi-asserted-by":"publisher","first-page":"1106","DOI":"10.1681\/ASN.2016050550","volume":"28","author":"Y Fu","year":"2017","unstructured":"Fu Y, Zhu J-Y, Richman A, Zhang Y, Xie X, Das JR, et al. APOL1-G1 in nephrocytes induces hypertrophy and accelerates cell death. J Am Soc Nephrol. 2017;28(4):1106\u201316.","journal-title":"J Am Soc Nephrol"},{"issue":"4","key":"1147_CR28","doi-asserted-by":"publisher","first-page":"1117","DOI":"10.1681\/ASN.2016050546","volume":"28","author":"E Kruzel-Davila","year":"2017","unstructured":"Kruzel-Davila E, Shemer R, Ofir A, Bavli-Kertselli I, Darlyuk-Saadon I, Oren-Giladi P, et al. APOL1-mediated cell injury involves disruption of conserved trafficking processes. J Am Soc Nephrol. 2017;28(4):1117\u201330.","journal-title":"J Am Soc Nephrol"},{"issue":"7227","key":"1147_CR29","doi-asserted-by":"publisher","first-page":"322","DOI":"10.1038\/nature07526","volume":"457","author":"H Weavers","year":"2009","unstructured":"Weavers H, Prieto-S\u00e1nchez S, Grawe F, Garcia-L\u00f3pez A, Artero R, Wilsch-Br\u00e4uninger M, et al. The insect nephrocyte is a podocyte-like cell with a filtration slit diaphragm. Nature. 2009;457(7227):322\u20136.","journal-title":"Nature"},{"issue":"2","key":"1147_CR30","doi-asserted-by":"publisher","first-page":"191","DOI":"10.1681\/ASN.2012080769","volume":"24","author":"F Zhang","year":"2013","unstructured":"Zhang F, Zhao Y, Han Z. An in vivo functional analysis system for renal gene discovery in Drosophila pericardial nephrocytes. J Am Soc Nephrol. 2013;24(2):191\u20137.","journal-title":"J Am Soc Nephrol"},{"issue":"6","key":"1147_CR31","doi-asserted-by":"publisher","first-page":"1303","DOI":"10.1016\/j.kint.2019.07.010","volume":"96","author":"H Lannon","year":"2019","unstructured":"Lannon H, Shah SS, Dias L, Blackler D, Alper SL, Pollak MR, et al. Apolipoprotein L1 (APOL1) risk variant toxicity depends on the haplotype background. Kidney Int. 2019;96(6):1303\u20137.","journal-title":"Kidney Int"},{"issue":"8","key":"1147_CR32","doi-asserted-by":"publisher","first-page":"1800","DOI":"10.1681\/ASN.2013070710","volume":"25","author":"X Xie","year":"2014","unstructured":"Xie X, Colberg-Poley AM, Das JR, Li J, Zhang A, Tang P, et al. The basic domain of HIV-tat transactivating protein is essential for its targeting to lipid rafts and regulating fibroblast growth factor-2 signaling in podocytes isolated from children with HIV-1-associated nephropathy. J Am Soc Nephrol. 2014;25(8):1800\u201313.","journal-title":"J Am Soc Nephrol"},{"key":"1147_CR33","doi-asserted-by":"publisher","DOI":"10.7554\/eLife.51185","volume":"9","author":"JA Giovinazzo","year":"2020","unstructured":"Giovinazzo JA, Thomson RP, Khalizova N, Zager PJ, Malani N, Rodriguez-Boulan E, et al. Apolipoprotein L-1 renal risk variants form active channels at the plasma membrane driving cytotoxicity. Elife. 2020;9: e51185.","journal-title":"Elife"},{"issue":"11","key":"1147_CR34","doi-asserted-by":"publisher","first-page":"3227","DOI":"10.1681\/ASN.2016111220","volume":"28","author":"D Granado","year":"2017","unstructured":"Granado D, M\u00fcller D, Krausel V, Kruzel-Davila E, Schuberth C, Eschborn M, et al. Intracellular APOL1 risk variants cause cytotoxicity accompanied by energy depletion. J Am Soc Nephrol. 2017;28(11):3227\u201338.","journal-title":"J Am Soc Nephrol"},{"issue":"4","key":"1147_CR35","doi-asserted-by":"publisher","first-page":"1093","DOI":"10.1681\/ASN.2016050567","volume":"28","author":"L Ma","year":"2017","unstructured":"Ma L, Chou JW, Snipes JA, Bharadwaj MS, Craddock AL, Cheng D, et al. APOL1 renal-risk variants induce mitochondrial dysfunction. J Am Soc Nephrol. 2017;28(4):1093\u2013105.","journal-title":"J Am Soc Nephrol"},{"issue":"12","key":"1147_CR36","doi-asserted-by":"publisher","first-page":"2355","DOI":"10.1681\/ASN.2019020114","volume":"30","author":"SS Shah","year":"2019","unstructured":"Shah SS, Lannon H, Dias L, Zhang J-Y, Alper SL, Pollak MR, et al. APOL1 kidney risk variants induce cell death via mitochondrial translocation and opening of the mitochondrial permeability transition pore. J Am Soc Nephrol. 2019;30(12):2355\u201368.","journal-title":"J Am Soc Nephrol"},{"issue":"5733","key":"1147_CR37","doi-asserted-by":"publisher","first-page":"469","DOI":"10.1126\/science.1114566","volume":"309","author":"D P\u00e9rez-Morga","year":"2005","unstructured":"P\u00e9rez-Morga D, Vanhollebeke B, Paturiaux-Hanocq F, Nolan DP, Lins L, Hombl\u00e9 F, et al. Apolipoprotein L-I promotes trypanosome lysis by forming pores in lysosomal membranes. Science. 2005;309(5733):469\u201372.","journal-title":"Science"},{"key":"1147_CR38","doi-asserted-by":"publisher","DOI":"10.1042\/BSR20171713","author":"H Wen","year":"2018","unstructured":"Wen H, Kumar V, Lan X, Shoshtari SSM, Eng JM, Zhou X, et al. APOL1 risk variants cause podocytes injury through enhancing endoplasmic reticulum stress. 2018. Biosci Rep. https:\/\/doi.org\/10.1042\/BSR20171713."},{"key":"1147_CR39","doi-asserted-by":"publisher","DOI":"10.1016\/j.kint.2021.12.031","author":"L Gerstner","year":"2022","unstructured":"Gerstner L, Chen M, Kampf LL, Milosavljevic J, Lang K, Schneider R, et al. Inhibition of endoplasmic reticulum stress signaling rescues cytotoxicity of human apolipoprotein-L1 risk variants in Drosophila. Kidney Int. 2022. https:\/\/doi.org\/10.1016\/j.kint.2021.12.031.","journal-title":"Kidney Int"},{"issue":"1","key":"1147_CR40","doi-asserted-by":"publisher","DOI":"10.1016\/j.isci.2021.103717","volume":"25","author":"E Kruzel-Davila","year":"2022","unstructured":"Kruzel-Davila E, Bavli-Kertselli I, Ofir A, Cheatham AM, Shemer R, Zaknoun E, et al. Endoplasmic reticulum-translocation is essential for APOL1 cellular toxicity. iScience. 2022;25(1): 103717.","journal-title":"iScience"},{"issue":"3","key":"1147_CR41","doi-asserted-by":"publisher","first-page":"869","DOI":"10.1681\/ASN.2016121322","volume":"29","author":"JF O\u2019Toole","year":"2018","unstructured":"O\u2019Toole JF, Schilling W, Kunze D, Madhavan SM, Konieczkowski M, Gu Y, et al. ApoL1 overexpression drives variant-independent cytotoxicity. J Am Soc Nephrol. 2018;29(3):869\u201379.","journal-title":"J Am Soc Nephrol"},{"issue":"9","key":"1147_CR42","doi-asserted-by":"publisher","first-page":"2083","DOI":"10.1681\/ASN.2020010079","volume":"31","author":"S Datta","year":"2020","unstructured":"Datta S, Kataria R, Zhang J-Y, Moore S, Petitpas K, Mohamed A, et al. Kidney disease-associated APOL1 variants have dose-dependent, dominant toxic gain-of-function. J Am Soc Nephrol. 2020;31(9):2083\u201396.","journal-title":"J Am Soc Nephrol"},{"key":"1147_CR43","doi-asserted-by":"publisher","DOI":"10.1172\/jci.insight.92581","author":"SM Madhavan","year":"2017","unstructured":"Madhavan SM, O\u2019Toole JF, Konieczkowski M, Barisoni L, Thomas DB, Ganesan S, et al. APOL1 variants change C-terminal conformational dynamics and binding to SNARE protein VAMP8. JCI Insight. 2017. https:\/\/doi.org\/10.1172\/jci.insight.92581.","journal-title":"JCI Insight"}],"container-title":["Cell &amp; Bioscience"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13578-023-01147-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s13578-023-01147-8\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13578-023-01147-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,11,4]],"date-time":"2023-11-04T03:10:02Z","timestamp":1699067402000},"score":1,"resource":{"primary":{"URL":"https:\/\/cellandbioscience.biomedcentral.com\/articles\/10.1186\/s13578-023-01147-8"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,11,4]]},"references-count":43,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2023,12]]}},"alternative-id":["1147"],"URL":"https:\/\/doi.org\/10.1186\/s13578-023-01147-8","relation":{"references":[{"id-type":"uri","id":"","asserted-by":"subject"}]},"ISSN":["2045-3701"],"issn-type":[{"value":"2045-3701","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,11,4]]},"assertion":[{"value":"23 June 2023","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"12 October 2023","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"4 November 2023","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Not applicable.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare that they have no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"199"}}